GLI
ABMD

Guardian Life Insurance’s Abiomed Inc ABMD Stock Holding History

Guardian Life Insurance’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-126
Closed -$21K – 488
2019
Q4 		$21K Hold
126
– – 0.01% 481
2019
Q3 		$22K Hold
126
– – ﹤0.01% 481
2019
Q2 		$33K Hold
126
– – ﹤0.01% 410
2019
Q1 		$36K Hold
126
– – ﹤0.01% 386
2018
Q4 		$41K Hold
126
– – 0.01% 317
2018
Q3 		$57K Buy
126
+10
+9% +$3.94K 0.01% 280
2018
Q2 		$47K Buy
+116
New +$42K 0.01% 307

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Guardian Life Insurance's ABMD Position: Q1 2020 in Review

Guardian Life Insurance sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 126 shares — an estimated $21K sold.

Guardian Life Insurance first reported a position in ABMD in Q2 2018 and held it in 7 quarters. The position peaked at $57K in Q3 2018. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Guardian Life Insurance reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • Guardian Life Insurance sold 126 Abiomed Inc shares in Q1 2020, an estimated $21K.
  • Guardian Life Insurance first reported a position in Abiomed Inc in Q2 2018 and held it in 7 quarters.
  • Guardian Life Insurance's Abiomed Inc position peaked at $57K in Q3 2018.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Guardian Life Insurance's 13F filing for Q1 2020.